This topic contains a solution. Click here to go to the answer

Author Question: A patient is about to begin treatment for latent tuberculosis with a short course of daily rifampin. ... (Read 31 times)

jlmhmf

  • Hero Member
  • *****
  • Posts: 552
A patient is about to begin treatment for latent tuberculosis with a short course of daily rifampin. The patient asks why rifapentine (Priftin) cannot be used, because it can be given twice weekly.
 
  What will the nurse tell this patient about rifapentine?
  a. It is more toxic than rifampin.
  b. It is not approved for treatment of latent TB.
  c. It is not well absorbed and thus not as effective.
  d. It will stain contact lenses orange.

Question 2

A patient who is being treated for HIV infection has a 5-mm area of induration after a routine TST. The patient's chest radiograph is normal, and there are no other physical findings. The nurse will expect this patient to begin treatment with which drugs?
 
  a. Isoniazid and rifabutin
  b. Isoniazid and rifampin
  c. Isoniazid and rifapentine
  d. Isoniazid and pyrazinamide



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

miss_1456@hotmail.com

  • Sr. Member
  • ****
  • Posts: 289
Answer to Question 1

ANS: B
Rifapentine is indicated only for pulmonary TB. Rifapentine's toxicity is similar to that of rifampin. Rifapentine is well absorbed. Both drugs stain contact lenses.

Answer to Question 2

ANS: A
Rifabutin is used off-label as an alternative to rifampin to treat TB in patients with HIV, because it has less impact on the metabolism of protease inhibitors. The effects of rifapentine on protease inhibitors is similar to those of rifampin. Pyrazinamide is not indicated.




jlmhmf

  • Member
  • Posts: 552
Reply 2 on: Jul 23, 2018
Excellent


cassie_ragen

  • Member
  • Posts: 347
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.

For a complete list of videos, visit our video library